Cutler Group LP Celularity Inc Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	SELL	$0.56 - $1.15 $68,712 - $141,105	-122,700 Reduced 99.11%	1,100 $0
Q4 2022 Feb 07, 2023	SELL	$1.08 - $2.35 $50,004 - $108,805	-46,300 Reduced 27.22%	123,800 $3,000
Q3 2022 Oct 25, 2022	SELL	$0.43 - $4.31 $25,972 - $260,323	-60,400 Reduced 26.2%	170,100 $5,000
Q2 2022 Aug 04, 2022	BUY	$2.81 - $12.91 $288,868 - $1.33 Million	102,800 Added 80.5%	230,500 $15,000
Q1 2022 Apr 14, 2022	SELL	$3.81 - $9.79 $152,781 - $392,578	-40,100 Reduced 23.9%	127,700 $158,000
Q4 2021 Jan 18, 2022	SELL	$4.64 - $7.46 $900,623 - $1.45 Million	-194,100 Reduced 53.63%	167,800 $10,000
Q3 2021 Oct 26, 2021	BUY	$6.05 - $12.15 $2.19 Million - $4.4 Million	361,900 New	361,900 $92,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.